Advertisement

Topics

Crowdsourcing and competition brings international perspectives to prostate cancer treatment

17:00 EDT 4 Aug 2017 | ecancermedicalscience

The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been...

Original Article: Crowdsourcing and competition brings international perspectives to prostate cancer treatment

NEXT ARTICLE

More From BioPortfolio on "Crowdsourcing and competition brings international perspectives to prostate cancer treatment"

Quick Search
Advertisement